VIKING THERAPEUTICS INC (VKTX) Forecast, Price Target & Analyst Ratings

NASDAQ:VKTX • US92686J1060

Current stock price

35.53 USD
-0.48 (-1.33%)
At close:
35.59 USD
+0.06 (+0.17%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VIKING THERAPEUTICS INC (VKTX).

Forecast Snapshot

Consensus Price Target

Price Target
$95.46
+ 168.67% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 21, 2026
Period
Q1 / 2026
EPS Estimate
-$1.09
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.83%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$95.46
Upside
+ 168.67%
From current price of $35.53 to mean target of $95.46, Based on 24 analyst forecasts
Low
$35.35
Median
$102.00
High
$131.25

Price Target Revisions

1 Month
-0.50%
3 Months
0.36%

Price Target Summary

24 Wall Street analysts provided a forecast for the next 12 months for VKTX. The average price target is 95.46 USD. This implies a price increase of 168.67% is expected in the next year compared to the current price of 35.53.
The average price target has been revised upward by 0.36% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

VKTX Current Analyst RatingVKTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

VKTX Historical Analyst RatingsVKTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
85.83%
VKTX was analyzed by 24 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about VKTX.
In the previous month the buy percentage consensus was at a similar level.
VKTX was analyzed by 24 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-11-12Canaccord GenuityMaintains Buy -> Buy
2025-10-29Canaccord GenuityInitiate Buy
2025-10-24JP MorganMaintains Overweight -> Overweight
2025-10-23Morgan StanleyMaintains Overweight -> Overweight
2025-09-29HC Wainwright & Co.Reiterate Buy -> Buy
2025-09-22BTIGReiterate Buy -> Buy
2025-08-19HC Wainwright & Co.Reiterate Buy -> Buy
2025-07-24Raymond JamesMaintains Strong Buy -> Strong Buy
2025-07-24CitigroupMaintains Neutral -> Neutral
2025-06-25HC Wainwright & Co.Reiterate Buy -> Buy
2025-04-28Cantor FitzgeraldInitiate Overweight
2025-04-28Truist SecuritiesReiterate Buy -> Buy
2025-04-24Morgan StanleyMaintains Overweight -> Overweight
2025-04-24HC Wainwright & Co.Reiterate Buy -> Buy
2025-04-17HC Wainwright & Co.Reiterate Buy -> Buy
2025-04-08Goldman SachsInitiate Neutral
2025-03-26HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-11HC Wainwright & Co.Reiterate Buy -> Buy
2025-02-13ScotiaBankInitiate Sector Outperform
2025-02-07B. Riley SecuritiesReiterate Buy -> Buy
2025-02-07Maxim GroupMaintains Buy -> Buy
2025-02-07CitigroupInitiate Neutral
2025-02-06Raymond JamesMaintains Strong Buy -> Strong Buy
2025-02-06Piper SandlerMaintains Overweight -> Overweight
2025-02-06HC Wainwright & Co.Reiterate Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 21, 2026
Period
Q1 / 2026
EPS Estimate
-$1.09
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-165.81%
Number of Analysts
17

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-14.21%
EPS (3 Months)
-13.32%

Next Earnings Summary

VKTX is expected to report earnings on 4/21/2026. The consensus EPS estimate for the next earnings is -1.09 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
VKTX revenue by date.VKTX revenue by date.
N/AN/AN/AN/A
245.99%		N/A
168.04%		N/A
81.55%		N/A
54.34%		N/A
44.86%
EBITDA
YoY % growth
VKTX ebitda by date.VKTX ebitda by date.
N/AN/AN/AN/AN/A
-21.76%		N/A
-30.72%		N/A
-38.37%		N/A
-17.68%		-100.535M
-45.16%		-150.575M
-49.77%		N/A
-119.21%		N/A
-62.10%		N/A
-21.69%		N/A
7.67%		N/A
19.69%		N/A
113.57%		N/A
826.56%		N/A
104.50%		N/A
68.01%
EBIT
YoY % growth
VKTX ebit by date.VKTX ebit by date.
-12M-13.85M
-15.42%		-19.07M
-37.69%		-26.16M
-37.18%		-32.69M
-24.96%		-42.66M
-30.50%		-55.68M
-30.52%		-70.36M
-26.36%		-100.827M
-43.30%		-150.921M
-49.68%		-393.342M
-160.63%		N/A
-32.22%		N/A
-11.89%		N/A
2.94%		N/A
31.05%		N/A
163.73%		N/A
365.77%		N/A
104.24%		N/A
73.19%
Operating Margin
VKTX operating margin by date.VKTX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
VKTX eps by date.VKTX eps by date.
-3.56-1.00
71.91%		-0.80
20.00%		-0.39
51.25%		-0.36
7.69%		-0.54
-50.00%		-0.72
-33.33%		-0.91
-26.39%		-0.92
-1.10%		-1.00
-8.70%		-3.18
-218.00%		N/A
-40.65%		N/A
-7.31%		N/A
9.94%		N/A
58.56%		N/A
306.72%		N/A
183.69%		N/A
78.81%		N/A
60.75%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-1.09
-165.81%		-1.10
-90.07%		-1.03
-26.91%		-1.10
20.07%		-0.98
10.15%		-0.97
12.10%		-0.97
5.73%		-1.17
-6.34%
Revenue
Q2Q % growth		N/AN/AN/AN/A
EBITDA
Q2Q % growth		-132.099M
-138.63%		-126.844M
-70.60%		-93.539M
-13.64%		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-129.348M
-133.19%		-129.123M
-73.15%		-120.097M
-21.85%		-137.432M
16.58%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

VKTX Yearly Revenue VS EstimatesVKTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 2032 2033 1B 2B 3B 4B 5B
VKTX Yearly EPS VS EstimatesVKTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 20 30

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-10.77%
EPS Next 5 Year
25.91%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-20.98%
EBIT Next 5 Year
17.00%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

VIKING THERAPEUTICS INC / VKTX Forecast FAQ

What is the average price target for VIKING THERAPEUTICS INC (VKTX) stock?

24 analysts have analysed VKTX and the average price target is 95.46 USD. This implies a price increase of 168.67% is expected in the next year compared to the current price of 35.53.

When does VIKING THERAPEUTICS INC (VKTX) report earnings?

VIKING THERAPEUTICS INC (VKTX) will report earnings on 2026-04-21, after the market close.

What are the consensus estimates for VKTX stock next earnings?

The consensus EPS estimate for the next earnings of VIKING THERAPEUTICS INC (VKTX) is -1.09 USD and the consensus revenue estimate is 0 USD.

How many analysts cover VIKING THERAPEUTICS INC (VKTX) stock?

The number of analysts covering VIKING THERAPEUTICS INC (VKTX) is 24.